119 related articles for article (PubMed ID: 25740107)
1. The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia.
Matsuo H; Goyama S; Kamikubo Y; Adachi S
Haematologica; 2015 Mar; 100(3):e116-7. PubMed ID: 25740107
[No Abstract] [Full Text] [Related]
2. The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features.
Eveillard M; Delaunay J; Richebourg S; Lodé L; Garand R; Wuillème S; Duhoux F; Antoine-Poirel H; Godon C; Béné MC
Haematologica; 2015 Mar; 100(3):e114-5. PubMed ID: 25740106
[No Abstract] [Full Text] [Related]
3. EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.
Matsuo H; Kajihara M; Tomizawa D; Watanabe T; Saito AM; Fujimoto J; Horibe K; Kodama K; Tokumasu M; Itoh H; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Shiba N; Ohki K; Hayashi Y; Yamashita Y; Shimada A; Tanaka S; Adachi S
Haematologica; 2014 Nov; 99(11):e225-7. PubMed ID: 25015941
[No Abstract] [Full Text] [Related]
4. Marked thrombocytosis and dysmegakaryopoiesis in acute myeloid leukemia with t(2;3)(p22;q26.2) and EVI1 rearrangement.
Yamamoto K; Okamura A; Sanada Y; Yakushijin K; Matsuoka H; Minami H
Ann Hematol; 2013 Dec; 92(12):1713-5. PubMed ID: 23604431
[No Abstract] [Full Text] [Related]
5. Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia.
Su G; Lian X; Tan D; Tao H; Liu H; Chen S; Yin H; Wu D; Yin B
Leuk Lymphoma; 2015 Feb; 56(2):472-9. PubMed ID: 24828867
[TBL] [Abstract][Full Text] [Related]
6. 3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review.
De Braekeleer M; Le Bris MJ; De Braekeleer E; Basinko A; Morel F; Douet-Guilbert N
Future Oncol; 2015; 11(11):1675-86. PubMed ID: 26043219
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia.
Vázquez I; Maicas M; Cervera J; Agirre X; Marin-Béjar O; Marcotegui N; Vicente C; Lahortiga I; Gomez-Benito M; Carranza C; Valencia A; Brunet S; Lumbreras E; Prosper F; Gómez-Casares MT; Hernández-Rivas JM; Calasanz MJ; Sanz MA; Sierra J; Odero MD
Haematologica; 2011 Oct; 96(10):1448-56. PubMed ID: 21750091
[TBL] [Abstract][Full Text] [Related]
8. High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group.
Ho PA; Alonzo TA; Gerbing RB; Pollard JA; Hirsch B; Raimondi SC; Cooper T; Gamis AS; Meshinchi S
Br J Haematol; 2013 Sep; 162(5):670-7. PubMed ID: 23826732
[TBL] [Abstract][Full Text] [Related]
9. Improved classification of MLL-AF9-positive acute myeloid leukemia patients based on BRE and EVI1 expression.
Noordermeer SM; Monteferrario D; Sanders MA; Bullinger L; Jansen JH; van der Reijden BA
Blood; 2012 May; 119(18):4335-7. PubMed ID: 22555662
[No Abstract] [Full Text] [Related]
10. Dysregulated EVI1 expression in myeloid malignancies.
Pardanani A
Leuk Lymphoma; 2006 Dec; 47(12):2443-4. PubMed ID: 17169788
[No Abstract] [Full Text] [Related]
11. Reverse transcriptase-polymerase chain reaction based quantification of the combined MDS-EVI1/EVI1 gene in acute myeloid leukemia.
Weisser M; Kern W; Schoch C; Tschulik C; Hiddemann W; Haferlach T; Schnittger S
Leuk Lymphoma; 2006 Dec; 47(12):2645-7. PubMed ID: 17169810
[No Abstract] [Full Text] [Related]
12. Expression of BEX1 in acute myeloid leukemia with MLL rearrangements.
Quentmeier H; Tonelli R; Geffers R; Pession A; Uphoff CC; Drexler HG
Leukemia; 2005 Aug; 19(8):1488-9. PubMed ID: 15920485
[No Abstract] [Full Text] [Related]
13. Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells.
Eguchi-Ishimae M; Eguchi M; Ohyashiki K; Yamagata T; Mitani K
Int J Hematol; 2009 Mar; 89(2):253-256. PubMed ID: 19241117
[No Abstract] [Full Text] [Related]
14. Review: Aberrant EVI1 expression in acute myeloid leukaemia.
Hinai AA; Valk PJ
Br J Haematol; 2016 Mar; 172(6):870-8. PubMed ID: 26729571
[TBL] [Abstract][Full Text] [Related]
15. A murine model of acute myeloid leukemia with Evi1 overexpression and autocrine stimulation by an intracellular form of GM-CSF in DA-3 cells.
Cardona ME; Simonson OE; Oprea II; Moreno PM; Silva-Lara MF; Mohamed AJ; Christensson B; Gahrton G; Dilber MS; Smith CI; Arteaga HJ
Leuk Lymphoma; 2016; 57(1):183-92. PubMed ID: 25907616
[TBL] [Abstract][Full Text] [Related]
16. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
17. The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia.
Fenouille N; Bassil CF; Ben-Sahra I; Benajiba L; Alexe G; Ramos A; Pikman Y; Conway AS; Burgess MR; Li Q; Luciano F; Auberger P; Galinsky I; DeAngelo DJ; Stone RM; Zhang Y; Perkins AS; Shannon K; Hemann MT; Puissant A; Stegmaier K
Nat Med; 2017 Mar; 23(3):301-313. PubMed ID: 28191887
[TBL] [Abstract][Full Text] [Related]
18. High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML.
Jo A; Mitani S; Shiba N; Hayashi Y; Hara Y; Takahashi H; Tsukimoto I; Tawa A; Horibe K; Tomizawa D; Taga T; Adachi S; Yoshida T; Ichikawa H
Leukemia; 2015 May; 29(5):1076-83. PubMed ID: 25567132
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
20. Deletion of sequences telomeric of the EVI1 gene in 3q26 associated with a novel pericentric inv(3)(p25q26) in a patient with acute myelogenous leukemia.
Wieser R; Lechner K; Valent P; Fonatsch C
Haematologica; 2003 Dec; 88(12):1427-9. PubMed ID: 14688000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
